-
Drugs
-
Risk Evaluation and Mitigation Strategies (REMS) Letters to Sponsor/Applicants Requesting Labeling Changes
Metoclopramide
- Metoclopramide (NDA Reglan tablets and injection) [PDF]
- Metoclopramide (ANDA Oral solution USP, 5 mg/5 mL) [PDF]
-
-

